Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Europe backs new leukaemia drugs from J&J and Gilead

[Reuters] – Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The . . . → Read More: Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Europe backs new leukaemia drugs from J&J and Gilead Similar Articles: Gilead Sciences Inc (NASDAQ:GILD) | Gilead Sciences to Present at the 2014 UBS Healthcare Conference on Tuesday, May 20 Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences Announces First Quarter 2014 Financial Results Stock Update: Eli Lilly & Company (NYSE:LLY) – EU agency backs new drugs from J&J, Lilly, Takeda
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.